<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37090595</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2023</Year><Month>Apr</Month><Day>12</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>Autoantibody production is enhanced after mild SARS-CoV-2 infection despite vaccination in individuals with and without long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2023.04.07.23288243</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2023.04.07.23288243</ELocationID><Abstract><AbstractText>Long COVID patients who experienced severe acute SARS-CoV-2 infection can present with humoral autoimmunity. However, whether mild SARS-CoV-2 infection increases autoantibody responses and whether vaccination can decrease autoimmunity in long COVID patients is unknown. Here, we demonstrate that mild SARS-CoV-2 infection increases autoantibodies associated with systemic lupus erythematosus (SLE) and inflammatory myopathies in long COVID patients with persistent neurologic symptoms to a greater extent than COVID convalescent controls at 8 months post-infection. Furthermore, high titers of SLE-associated autoantibodies in long COVID patients are associated with impaired cognitive performance and greater symptom severity, and subsequent vaccination/booster does not decrease autoantibody titers. In summary, we found that mild SARS-CoV-2 infection can induce persistent humoral autoimmunity in both long COVID patients and healthy COVID convalescents, suggesting that a reappraisal of vaccination and mitigation strategies is warranted.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Visvabharathy</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Davee Department of Neurology, Feinberg School of Medicine, Northwestern University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Genomics and Microarray Core Facility, University of Texas Southwestern Medical Center.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orban</LastName><ForeName>Z S</ForeName><Initials>ZS</Initials><AffiliationInfo><Affiliation>Davee Department of Neurology, Feinberg School of Medicine, Northwestern University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yarnoff</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Davee Department of Neurology, Feinberg School of Medicine, Northwestern University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palacio</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimenez</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Davee Department of Neurology, Feinberg School of Medicine, Northwestern University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>P H</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Davee Department of Neurology, Feinberg School of Medicine, Northwestern University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penaloza-MacMaster</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koralnik</LastName><ForeName>I J</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Davee Department of Neurology, Feinberg School of Medicine, Northwestern University.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP2 DA051912</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG059291</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 EB027049</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo><CoiStatement>Declaration of interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>3</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37090595</ArticleId><ArticleId IdType="pmc">PMC10120795</ArticleId><ArticleId IdType="doi">10.1101/2023.04.07.23288243</ArticleId><ArticleId IdType="pii">2023.04.07.23288243</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>O&#x2019;Mahoney L.L., Routen A., Gillies C., Ekezie W., Welford A., Zhang A., Karamchandani U., Simms-Williams N., Cassambai S., Ardavani A., et al. (2023). The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine 55, 101762. 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H., Patel K., Greenwood D.C., Halpin S., Lewthwaite P., Salawu A., Eyre L., Breen A., O&#x2019;Connor R., Jones A., and Sivan M. (2020). Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. J Rehabil Med 52, jrm00063. 10.2340/16501977-2694.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2694</ArticleId><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L., Kannapadi N.V., Briggs J., Seal S.M., Battaglini D., Fanning J., Suen J., Robba C., Fraser J., and Cho S.M. (2022). Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci 434, 120162. 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Feikin D.R., Higdon M.M., Abu-Raddad L.J., Andrews N., Araos R., Goldberg Y., Groome M.J., Huppert A., O&#x2019;Brien K.L., Smith P.G., et al. (2022). Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet 399, 924&#x2013;944. 10.1016/S0140-6736(22)00152-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00152-0</ArticleId><ArticleId IdType="pmc">PMC8863502</ArticleId><ArticleId IdType="pubmed">35202601</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., and Xie Y. (2022). Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P., et al. (2021). Diverse functional autoantibodies in patients with COVID-19. Nature 595, 283&#x2013;288. 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral-Marques O., Halpert G., Schimke L.F., Ostrinski Y., Vojdani A., Baiocchi G.C., Freire P.P., Filgueiras I.S., Zyskind I., Lattin M.T., et al. (2022). Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity. Nat Commun 13, 1220. 10.1038/s41467-022-28905-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28905-5</ArticleId><ArticleId IdType="pmc">PMC8907309</ArticleId><ArticleId IdType="pubmed">35264564</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. (2022). Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185, 881&#x2013;895 e820. 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K., Jamil R., Chowdhury A., Mukherjee M., Venegas C., Miyasaki K., Zhang K., Patel Z., Salter B., Yuen A.C.Y., et al. (2023). Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur Respir J 61. 10.1183/13993003.00970-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Etter M.M., Martins T.A., Kulsvehagen L., Possnecker E., Duchemin W., Hogan S., Sanabria-Diaz G., Muller J., Chiappini A., Rychen J., et al. (2022). Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study. Nat Commun 13, 6777. 10.1038/s41467-022-34068-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34068-0</ArticleId><ArticleId IdType="pmc">PMC9645766</ArticleId><ArticleId IdType="pubmed">36351919</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C., DiBiase R.M., Jia D.T., Balabanov R., Ho S.U., et al. (2021). Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann Clin Transl Neurol 8, 1073&#x2013;1085. 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel S.A.M., Olde Hartman T.C., Lucassen P., and van Jaarsveld C.H.M. (2022). Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract 39, 159&#x2013;167. 10.1093/fampra/cmab076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmab076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez Giraldo G.S., Ali S.T., Kang A.K., Patel T.R., Budhiraja S., Gaelen J.I., Lank G.K., Clark J.R., Mukherjee S., Singer T., et al. (2023). Neurologic manifestations of long COVID differ based on acute COVID-19 severity. Ann Neurol. 10.1002/ana.26649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26649</ArticleId><ArticleId IdType="pmc">PMC10724021</ArticleId><ArticleId IdType="pubmed">36966460</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., Pastrana A., Ver A.T., Pangilinan F.C., Peligro P.J., Casimiro M., Guerrero J.J., Gellaco M.M.L., et al. (2022). Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine 53, 101624. 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali S.T., Kang A.K., Patel T.R., Clark J.R., Perez-Giraldo G.S., Orban Z.S., Lim P.H., Jimenez M., Graham E.L., Batra A., et al. (2022). Evolution of neurologic symptoms in non-hospitalized COVID-19 &#x201c;long haulers&#x201d;. Ann Clin Transl Neurol 9, 950&#x2013;961. 10.1002/acn3.51570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51570</ArticleId><ArticleId IdType="pmc">PMC9268866</ArticleId><ArticleId IdType="pubmed">35607826</ArticleId></ArticleIdList></Reference><Reference><Citation>Visvabharathy L., Hanson B., Orban Z., Lim P.H., Palacio N., Jain R., Liotta E.M., Penaloza-MacMaster P., and Koralnik I.J. (2021). Neuro-COVID long-haulers exhibit broad dysfunction in T cell memory generation and responses to vaccination. medRxiv. 10.1101/2021.08.08.21261763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.08.08.21261763</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergamaschi C., Terpos E., Rosati M., Angel M., Bear J., Stellas D., Karaliota S., Apostolakou F., Bagratuni T., Patseas D., et al. (2021). Systemic IL-15, IFN-gamma, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients. Cell Rep 36, 109504. 10.1016/j.celrep.2021.109504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109504</ArticleId><ArticleId IdType="pmc">PMC8299183</ArticleId><ArticleId IdType="pubmed">34352226</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub S., Dikmen S.S., Heaton R.K., Tulsky D.S., Zelazo P.D., Bauer P.J., Carlozzi N.E., Slotkin J., Blitz D., Wallner-Allen K., et al. (2013). Cognition assessment using the NIH Toolbox. Neurology 80, S54&#x2013;64. 10.1212/WNL.0b013e3182872ded.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182872ded</ArticleId><ArticleId IdType="pmc">PMC3662346</ArticleId><ArticleId IdType="pubmed">23479546</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C., Primus-de Jong C., Cleemput I., and Van den Heede K. (2022). Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med 54, 1473&#x2013;1487. 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamani R., Pouremamali R., and Rezaei N. (2022). Central neuroinflammation in Covid-19: a systematic review of 182 cases with encephalitis, acute disseminated encephalomyelitis, and necrotizing encephalopathies. Rev Neurosci 33, 397&#x2013;412. 10.1515/revneuro-2021-0082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2021-0082</ArticleId><ArticleId IdType="pubmed">34536341</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Rosen L.B., Zhang Q., Michailidis E., Hoffmann H.H., Zhang Y., Dorgham K., Philippot Q., Rosain J., Beziat V., et al. (2020). Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370. 10.1126/science.abd4585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Brussow H., and Brussow L. (2021). Clinical evidence that the pandemic from 1889 to 1891 commonly called the Russian flu might have been an earlier coronavirus pandemic. Microb Biotechnol 14, 1860&#x2013;1870. 10.1111/1751-7915.13889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1751-7915.13889</ArticleId><ArticleId IdType="pmc">PMC8441924</ArticleId><ArticleId IdType="pubmed">34254725</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramassy L., Oumarou Hama H., Costedoat C., Signoli M., Verna E., La Scola B., Aboudharam G., Barbieri R., and Drancourt M. (2022). Paleoserology points to Coronavirus as possible causative pathogens of the &#x2018;Russian flu&#x2019;. Microb Biotechnol 15, 1943&#x2013;1945. 10.1111/1751-7915.14058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1751-7915.14058</ArticleId><ArticleId IdType="pmc">PMC9111311</ArticleId><ArticleId IdType="pubmed">35384322</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M., Rodriguez Y., Acosta-Ampudia Y., Monsalve D.M., Zhu C., Li Q.Z., Ramirez-Santana C., and Anaya J.M. (2022). Autoimmunity is a hallmark of post-COVID syndrome. J Transl Med 20, 129. 10.1186/s12967-022-03328-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03328-4</ArticleId><ArticleId IdType="pmc">PMC8924736</ArticleId><ArticleId IdType="pubmed">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Selmi C., Bin G., and Gershwin M.E. (2018). The long and latent road to autoimmunity. Cell Mol Immunol 15, 543&#x2013;546. 10.1038/s41423-018-0018-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-018-0018-y</ArticleId><ArticleId IdType="pmc">PMC6078962</ArticleId><ArticleId IdType="pubmed">29568115</ArticleId></ArticleIdList></Reference><Reference><Citation>James J.A., Chen H., Young K.A., Bemis E.A., Seifert J., Bourn R.L., Deane K.D., Demoruelle M.K., Feser M., O&#x2019;Dell J.R., et al. (2019). Latent autoimmunity across disease-specific boundaries in at-risk first-degree relatives of SLE and RA patients. EBioMedicine 42, 76&#x2013;85. 10.1016/j.ebiom.2019.03.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.03.063</ArticleId><ArticleId IdType="pmc">PMC6491794</ArticleId><ArticleId IdType="pubmed">30952617</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., and Al-Aly Z. (2022). Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med 28, 2398&#x2013;2405. 10.1038/s41591-022-02051-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang S.E., Feng A., Meng W., Apostolidis S.A., Mack E., Artandi M., Barman L., Bennett K., Chakraborty S., Chang I., et al. (2021). New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat Commun 12, 5417. 10.1038/s41467-021-25509-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25509-3</ArticleId><ArticleId IdType="pmc">PMC8440763</ArticleId><ArticleId IdType="pubmed">34521836</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Abellan J., Fernandez M., Padilla S., Garcia J.A., Agullo V., Lozano V., Ena N., Garcia-Sanchez L., Gutierrez F., and Masia M. (2022). Immunologic phenotype of patients with long-COVID syndrome of 1-year duration. Front Immunol 13, 920627. 10.3389/fimmu.2022.920627.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.920627</ArticleId><ArticleId IdType="pmc">PMC9451924</ArticleId><ArticleId IdType="pubmed">36090973</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter A.G., Shields A.M., Karim A., Birch D., Faustini S.E., Steadman L., Ward K., Plant T., Reynolds G., Veenith T., et al. (2021). Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection. Clin Exp Immunol 205, 99&#x2013;105. 10.1111/cei.13623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13623</ArticleId><ArticleId IdType="pmc">PMC8239842</ArticleId><ArticleId IdType="pubmed">34082475</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G., Wang Q., Wang Y., Liu C., Wang L., Chen H., Jiao T., Hu C., Lei X., Guo L., et al. (2021). Presence of Anti-MDA5 Antibody and Its Value for the Clinical Assessment in Patients With COVID-19: A Retrospective Cohort Study. Front Immunol 12, 791348. 10.3389/fimmu.2021.791348.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.791348</ArticleId><ArticleId IdType="pmc">PMC8720853</ArticleId><ArticleId IdType="pubmed">34987516</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias Junior A.G., Sampaio N.G., and Rehwinkel J. (2019). A Balancing Act: MDA5 in Antiviral Immunity and Autoinflammation. Trends Microbiol 27, 75&#x2013;85. 10.1016/j.tim.2018.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2018.08.007</ArticleId><ArticleId IdType="pmc">PMC6319154</ArticleId><ArticleId IdType="pubmed">30201512</ArticleId></ArticleIdList></Reference><Reference><Citation>Manry J., Bastard P., Gervais A., Le Voyer T., Rosain J., Philippot Q., Michailidis E., Hoffmann H.H., Eto S., Garcia-Prat M., et al. (2022). The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies. Proc Natl Acad Sci U S A 119, e2200413119. 10.1073/pnas.2200413119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2200413119</ArticleId><ArticleId IdType="pmc">PMC9173764</ArticleId><ArticleId IdType="pubmed">35576468</ArticleId></ArticleIdList></Reference><Reference><Citation>Visvabharathy L., Orban Z.S., and Koralnik I.J. (2022). Case report: Treatment of long COVID with a SARS-CoV-2 antiviral and IL-6 blockade in a patient with rheumatoid arthritis and SARS-CoV-2 antigen persistence. Front Med (Lausanne) 9, 1003103. 10.3389/fmed.2022.1003103.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1003103</ArticleId><ArticleId IdType="pmc">PMC9537824</ArticleId><ArticleId IdType="pubmed">36213654</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B., Fan J., Huang J., Guo E., Fu Y., Liu S., Xiao R., Liu C., Lu F., Qin T., et al. (2021). Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection. Nat Commun 12, 3501. 10.1038/s41467-021-23621-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23621-y</ArticleId><ArticleId IdType="pmc">PMC8190301</ArticleId><ArticleId IdType="pubmed">34108465</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A., Koch R., Jukic A., Pfister A., Meyer M., Rossler A., Kimpel J., Adolph T.E., and Tilg H. (2022). Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases. Gastroenterology 163, 495&#x2013;506 e498. 10.1053/j.gastro.2022.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaycox J.R., Lucas C., Yildirim I., Dai Y., Wang E.Y., Monteiro V., Lord S., Carlin J., Kita M., Buckner J.H., et al. (2023). SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity. Nat Commun 14, 1299. 10.1038/s41467-023-36686-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-36686-8</ArticleId><ArticleId IdType="pmc">PMC9996559</ArticleId><ArticleId IdType="pubmed">36894554</ArticleId></ArticleIdList></Reference><Reference><Citation>Palacio N., Dangi T., Chung Y.R., Wang Y., Loredo-Varela J.L., Zhang Z., and Penaloza-MacMaster P. (2020). Early type I IFN blockade improves the efficacy of viral vaccines. J Exp Med 217. 10.1084/jem.20191220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20191220</ArticleId><ArticleId IdType="pmc">PMC7953731</ArticleId><ArticleId IdType="pubmed">32820330</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>